The cause of a life-threatening condition that can lead to heart failure in pregnant women could be genetic, a global study has found.

Peripartum cardiomyopathy (PPCM) can lead to a woman developing heart failure in late pregnancy or shortly after delivery.

Royal Brompton Hospital and Penn Cardiovascular Institute in the US have published new findings showing a sequence of key gene variants in women with the condition.

Already known risk factors include pre-existing hypertension and pre-eclampsia, and most common symptoms of the condition are breathlessness and palpitations. While these can usually be treated with drugs, such as ace inhibitors and beta blockers, in the most severe cases, a heart transplant can be the only long-term option.

The most common symptoms of the condition are breathlessness and palpitations

Researches set out to determine whether the condition is linked to the genetic mutations responsible for a condition called dilated cardiomyopathy (DCM), which shares similarities with PPCM. These include heart enlargement, drop in heart function, and even sudden death.

One in five cases are caused by variants in the TTN gene.

Researchers used a sample of 172 women with PPCM from six centres across the world, 332 people with DCM in the UK and 60,000 control subjects, and compared the prevalence of variants in 43 genes.

Around 15 per cent of PPCM patients were found to carry variants that disrupted important heart genes. This was significantly higher than the controls but similar to the patients with DCM (17 per cent). In particular, 10 per cent of women with PPCM had mutations of the TTN gene, compared with just 1.4 per cent of the controls.

This evidence suggests that PPCM can have very similar genetic characteristics to DCM, with variants of the TTN gene found to be the most prevalent genetic disposition of each disease.

Experts say the results have implications for the way the condition is treated in future and could save lives. For example, it may mean that relatives of PPCM patients are offered the same genetic screening as close families, to identify any cases as soon as possible.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.